ALCOA+ stands for Attributable, Legible, Contemporaneous, Original, Accurate (the five original principles), plus Complete, Consistent, Enduring, and Available (the four “+” extensions). These nine principles form the universally recognized data integrity framework for GxP environments. Developed by the FDA in the 1990s, ALCOA+ has been adopted by the WHO, PIC/S (PI 041-1), EMA, and MHRA as the standard for evaluating whether regulated data can be trusted during inspections.
Key Takeaways
- ALCOA+ defines nine data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
- Key guidance documents: FDA Data Integrity Guidance (2018), WHO TRS No. 996 Annex 5, PIC/S PI 041-1 (2021), MHRA GxP Data Integrity Guidance (2018).
- Shared login credentials are the most frequently cited ALCOA+ violation in FDA 483 observations.
- Data integrity findings have been among the top reasons for FDA warning letters since 2015, leading to import alerts and consent decrees.
- Immutable, hash-chained audit trails are the single most important technical control for ALCOA+ compliance in electronic systems.
This guide breaks down each ALCOA+ principle, explains how they apply to electronic records, identifies common violations, and offers practical strategies for building a data integrity culture in your organization.
What Does ALCOA+ Stand For?
ALCOA is an acronym for the five original data integrity principles: Attributable, Legible, Contemporaneous, Original, and Accurate. The “+” extension adds four additional principles: Complete, Consistent, Enduring, and Available. Together, these nine principles form ALCOA+ — the standard regulators use to assess whether data generated in GxP environments can be trusted.
Regulatory Basis for ALCOA+
ALCOA+ isn't itself a regulation, but it's referenced and endorsed by every major regulatory authority. The key guidance documents that incorporate ALCOA+ principles:
- FDA Guidance for Industry: Data Integrity and Compliance with Drug CGMP (2018). Explicitly references ALCOA and outlines expectations for electronic records under 21 CFR Part 11.
- WHO Technical Report Series No. 996, Annex 5 (2016). Guidance on Good Data and Record Management Practices, with a detailed interpretation of ALCOA+ in the context of pharmaceutical quality systems.
- PIC/S PI 041-1 (2021). Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments. Particularly influential since PIC/S guides are adopted by authorities in over 50 countries.
- MHRA GxP Data Integrity Guidance (2018). One of the most detailed regulatory guidance documents on data integrity, structured explicitly around ALCOA+ principles.
- EMA Questions and Answers on Data Integrity (2022). Clarifies expectations for GMP data integrity with practical examples.
Deep Dive: The Nine ALCOA+ Principles
1. Attributable
Every data entry, modification, deletion, and signature must be traceable to the specific individual who performed the action. Attribution answers the fundamental question: who did this, and when?
In practice, attributability requires:
- Unique user accounts. Every individual who interacts with data must have their own login credentials. Shared accounts, generic logins (e.g., “Lab1” or “Operator”), and shared passwords are among the most frequently cited data integrity violations.
- Audit trails. Systems must automatically record who performed each action, with a tamper-evident timestamp. Manual logbooks must include the individual's name or initials and the date/time of each entry.
- Electronic signatures. When data is approved, reviewed, or released, the electronic signature must be uniquely linked to the signatory and permanently associated with the signed record.
Common violation: Shared login credentials remain one of the most frequently cited findings in FDA 483 observations and EU GMP non-compliance reports. Even in legacy systems where technical limitations exist, organizations must implement compensating controls (such as manual sign-in logs cross-referenced with system entries) to maintain attributability.
2. Legible
Data must be readable, permanent, and understandable throughout its entire lifecycle, from creation through the end of the retention period. That includes both the data values and the metadata that gives them context (units of measurement, column headers, abbreviation definitions).
Key requirements for legibility include:
- Permanent recording media. Data must not be recorded in pencil, on sticky notes, or in formats that degrade over time. For electronic records, this means validated systems with reliable storage and backup.
- No obscured entries. In paper records, corrections must use a single-line strikethrough (original still legible). In electronic records, the original value must be preserved in the audit trail.
- Format preservation. Electronic records must remain readable even as technology evolves. Plan for format migration to prevent data from becoming inaccessible due to obsolete software or hardware.
3. Contemporaneous
Data must be recorded at the time the activity is performed, not after the fact. Contemporaneous recording ensures that data reflects the actual conditions and observations at the moment of the activity, rather than being subject to memory degradation, bias, or manipulation.
In practice, this means:
- Real-time recording. Laboratory observations, manufacturing parameters, and clinical assessments must be documented as they occur, not transcribed from memory at the end of a shift.
- Synchronized system clocks. Electronic systems must use synchronized, accurate time sources (ideally NTP-synchronized). Discrepancies between system timestamps and actual event times are a red flag during inspections.
- No backdating. Audit trails must make it impossible to change the timestamp of a record entry. If a late entry is necessary, it must be clearly identified as such with an explanation.
4. Original
Data must be the first capture of that information, or a verified certified true copy. The original record is the one that has the highest evidentiary value because it has not been through any transcription or transformation process that could introduce errors.
Key considerations include:
- First capture is the original. If data is first recorded on a scrap of paper and then transcribed into a logbook, the scrap of paper is the original. Discarding it is a data integrity violation.
- Certified true copies. When originals aren't practical to retain (e.g., instrument printouts on thermal paper), certified true copies are acceptable if the copy process is validated and verified against the original.
- Electronic originals. For electronic records, the data as stored in the validated system is the original. A PDF printout is a copy, not the original, unless the system is validated to produce certified true copies.
5. Accurate
Data must be correct, truthful, and free from errors. Accuracy means that the recorded data faithfully represents the actual observation, measurement, or activity. It also means that data has not been manipulated, fabricated, or selectively reported.
Accuracy requires:
- Calibrated instruments. Measurement devices must be calibrated against traceable standards and maintained within specification.
- Validated systems. Electronic systems must be validated to ensure that data input, processing, storage, and retrieval don't introduce errors.
- Error correction procedures. When errors are found, they must be corrected following documented procedures that preserve the original entry and record the reason for the correction.
- Verification and review. Critical data should be subject to independent review or second-person verification.
6. Complete
All data must be present, including repeat analyses, out-of-specification results, failed runs, and any data that was generated but not used in the final report. The completeness principle exists to prevent cherry-picking: selectively reporting favorable results while hiding unfavorable ones.
Completeness requires:
- No deletion without justification. Data must not be deleted without a documented, scientifically justified reason and appropriate authorization.
- All analyses reported. Repeat analyses must be reported alongside original analyses, with documented justification for the repeat.
- Metadata retention. Audit trails, system logs, and metadata are part of the complete record and must be retained alongside the primary data.
7. Consistent
Data must be chronologically ordered, internally coherent, and free from unexplained gaps. When events are recorded out of sequence, or when timestamps are inconsistent with the expected workflow, it raises questions about the reliability of the entire data set.
Signs of consistency issues include:
- Timestamps that are out of chronological order
- Gaps in sequential numbering (batch numbers, sample IDs, page numbers)
- Date/time discrepancies between related systems
- Processing times that are implausibly short or long
- Identical results across multiple analyses (suggesting copy/paste rather than actual measurement)
8. Enduring
Data must be recorded on durable media that will survive the full retention period. This principle addresses the physical and technological longevity of records.
- Paper records. Must use permanent ink on controlled paper stock. Thermal paper (common in instrument printouts) fades over time and must be photocopied or scanned, with the copy verified as a certified true copy.
- Electronic records. Must be stored on reliable media with appropriate backup and disaster recovery. Storage media degrade; plan for periodic migration to current technology.
- Long-term format viability. Proprietary file formats may become unreadable as software vendors discontinue products. Use or convert to widely supported formats (e.g., PDF/A for long-term archival).
9. Available
Data must be accessible for review, audit, and inspection at any point during the retention period. That means authorized personnel, including regulatory inspectors, can retrieve and review records in a reasonable timeframe.
- Retrieval capability. Organizations must be able to locate and produce specific records on request. This requires an organized filing system (physical or electronic) with reliable search and retrieval.
- Readable format. Archived data must be retrievable in a human-readable format. Storing data in encrypted or proprietary formats without maintaining the ability to decode them is an availability failure.
- Retention period compliance. Data must remain available for the full regulatory retention period. For clinical trial data under EU CTR 536/2014, this means 25 years.
What Are the Most Common ALCOA+ Violations in FDA Inspections?
Regulatory enforcement data shows clear patterns in the types of data integrity failures that trigger citations. The following are among the most frequently observed ALCOA+ violations in FDA 483 observations and warning letters:
- Shared login credentials (Attributable). Multiple operators using a single login, making it impossible to determine who performed an action.
- Deleting or overwriting data without audit trails (Original, Complete). Systems that allow deletion without retaining the original record and a documented reason.
- Backdating records (Contemporaneous, Consistent). Entering data later but recording it as if it were entered at the time of the activity.
- Testing into compliance (Complete, Accurate). Repeating analyses until an acceptable result is obtained, then reporting only the passing result.
- Disabling audit trail functionality (Attributable, Complete). Turning off audit trails to avoid recording certain actions.
- Uncontrolled use of scratch paper (Original, Legible). Recording data on informal media and discarding it after transcription.
- Insufficient system access controls (Attributable, Accurate). Users with excessive privileges that let them modify data outside their authorized scope.
Enforcement trend: Data integrity findings have been among the top reasons for FDA warning letters to pharmaceutical manufacturers since 2015. The FDA has taken increasingly aggressive enforcement action, including import alerts, consent decrees, and application integrity policy (AIP) invocations. Prevention is significantly less costly than remediation.
Electronic Records and ALCOA+
Electronic records systems present both advantages and risks for ALCOA+ compliance. Well-designed systems can enforce many ALCOA+ principles automatically. But poorly configured systems can create new integrity risks that are harder to detect than their paper equivalents.
Advantages of electronic systems for ALCOA+ compliance:
- Automatic attribution. User authentication links every action to a specific individual without relying on manual initials or signatures.
- Immutable audit trails. System-generated audit trails capture every action with precise timestamps, eliminating undetected changes.
- Contemporaneous timestamps. Electronic systems record events at the exact time they occur, removing the opportunity for backdating.
- Controlled access. Role-based permissions ensure users can only perform actions appropriate to their responsibilities.
Risks that must be managed:
- System configuration. Audit trails must be enabled and configured correctly. Default settings in some systems don't capture all GxP-relevant actions.
- Administrator access. System administrators with unrestricted access can potentially modify data or audit trails. Segregation of duties and independent audit trail storage are essential controls.
- Data migration. Moving data between systems risks data loss, format corruption, and metadata loss. Migration must be validated end-to-end.
How Do Audit Trails Support ALCOA+ Compliance?
A thorough, immutable audit trail is the single most important technical control for ALCOA+ compliance in electronic systems. A properly implemented audit trail directly supports multiple principles:
| ALCOA+ Principle | How Audit Trails Support It |
|---|---|
| Attributable | Records who performed each action with authenticated user identity |
| Legible | Preserves original values alongside modifications in readable format |
| Contemporaneous | Captures precise, system-generated timestamps for every event |
| Original | Preserves the first-captured data even when subsequent changes are made |
| Accurate | Enables detection of unauthorized changes through tamper-evident records |
| Complete | Captures all actions including deletions and failed attempts |
| Consistent | Provides chronological ordering of all events with verifiable timestamps |
| Enduring | Stored on validated, durable media with backup and recovery procedures |
| Available | Searchable and retrievable for the entire retention period |
Beyond basic audit trails: Certivo implements SHA-256 cryptographic hash chains in its audit trail, where each entry is mathematically linked to the previous one. This makes undetected tampering computationally infeasible, providing a level of integrity assurance that goes well beyond simple logging. Combined with independent hash storage for verification, this approach satisfies the most demanding regulatory expectations for audit trail integrity. See our compliance documentation for technical details.
Implementation Strategies for ALCOA+ Compliance
Achieving and maintaining ALCOA+ compliance takes a systematic approach spanning technology, processes, and organizational culture. These strategies provide a practical starting point:
- Conduct a data integrity risk assessment. Map all data flows in your organization, from raw data generation through final reporting. Identify where each ALCOA+ principle could be compromised and prioritize remediation based on risk to product quality and patient safety.
- Eliminate shared accounts and strengthen access controls. Ensure every user has unique credentials with appropriate role-based permissions. Implement two-factor authentication for critical actions such as data approval and electronic signatures.
- Enable and validate audit trail functionality. Audit trails must be active on all GxP-critical systems, configured to capture all relevant actions, and validated to confirm completeness and accuracy.
- Establish a routine audit trail review process. Don't wait for deviations or inspections to review audit trails. Build audit trail review into batch release, periodic quality reviews, and routine self-inspections.
- Validate all GxP computerized systems. Follow the GAMP 5 risk-based approach to system validation. Ensure that IQ, OQ, and PQ cover all ALCOA+-relevant system functions.
- Implement data backup and disaster recovery. Ensure that data is backed up regularly, backups are verified, and recovery procedures are tested. Document recovery time objectives and recovery point objectives.
- Train all personnel on data integrity. Training must cover ALCOA+ principles, organizational data integrity policies, system-specific procedures, and the consequences of data integrity failures.
- Monitor and measure. Establish metrics for data integrity performance (e.g., frequency of audit trail exceptions, out-of-specification investigation timeliness, training compliance rates) and report them to management regularly.
ALCOA+ Self-Assessment Checklist
Use the following questions to evaluate your organization's current ALCOA+ compliance posture:
- Do all users have unique, individual login credentials for every GxP system?
- Are audit trails enabled, immutable, and routinely reviewed on all critical systems?
- Is data recorded at the time the activity is performed, without routine transcription delays?
- Are original records preserved, even when corrections or amendments are made?
- Are instruments calibrated, systems validated, and data independently verified?
- Are all data retained, including out-of-specification results and repeat analyses?
- Are timestamps synchronized across systems and consistent with documented workflows?
- Can records survive the full retention period in a readable, accessible format?
- Can any record be located and produced for inspection within a reasonable timeframe?
- Is there a documented data integrity policy that personnel have been trained on?
- Are data integrity metrics tracked and reported to senior management?
- Is there a clear, accessible process for reporting data integrity concerns without fear of retaliation?
Building a Culture of Data Integrity
Technology and procedures alone won't guarantee data integrity. The PIC/S PI 041 guidance explicitly states that “a quality culture which encourages a scientific approach to problem solving, transparency and honesty, with supportive management oversight” is essential to effective data integrity.
Key elements of a data integrity culture include:
- Management commitment. Senior leadership must visibly prioritize data integrity, allocate adequate resources, and respond constructively (not punitively) when issues surface.
- Open reporting. Employees must feel safe reporting data integrity concerns, errors, and near-misses. A blame-oriented culture drives data integrity underground.
- Realistic expectations. Unrealistic production targets and understaffing are root causes of data integrity failures. Personnel need adequate time and resources to record data properly.
- Continuous improvement. Data integrity should be treated as an ongoing initiative, not a one-time remediation project. Regular self-inspections, trend analysis, and corrective actions should be part of the quality system lifecycle.
ALCOA+ compliance isn't just a regulatory obligation. It's how organizations ensure their data can be trusted. Every decision in life sciences, from batch release to regulatory submission to clinical trial reporting, depends on the integrity of the underlying data. Organizations that internalize these principles into daily operations build a foundation that withstands regulatory scrutiny and, more importantly, protects patient safety.
For more on how electronic records systems support data integrity, explore our guides on FDA 21 CFR Part 11 and GxP compliance for electronic records.